https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48720 Wed 29 Mar 2023 16:52:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51305 Wed 28 Feb 2024 16:11:03 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35200 Wed 26 Jun 2019 15:26:11 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25104 0.75 for 95.8% (no = 115) and between 0.5 and 0.75 for 4.2% (no = 5); the ICC for reproducibility was > 0.75 for 85% (no = 51), and between 0.5 and 0.75 for 15% (no = 9). In conclusion, the F-Scan system can be utilised to record repeatable and reproducible data in paediatric gait analysis.]]> Wed 11 Apr 2018 10:32:11 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55108 Wed 10 Apr 2024 08:52:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36838 Wed 08 Jul 2020 16:15:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48754 Wed 05 Apr 2023 13:48:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24336 .05 indicated statistical significance. An expert panel Delphi consensus (≥80%) was required for the endorsement of recommendations. Data Synthesis: All included studies were of high quality and analyzed the effects of multidisciplinary foot care, customized foot orthotics, and shoe inserts for the management of JIA. Custom-made foot orthotics and prefabricated shoe inserts displayed the greatest improvement in pain intensity, activity limitation, foot pain, and disability reduction (grades A, C+). Conclusions: The use of customized foot orthotics and prefabricated shoe inserts seems to be a good choice for managing foot pain and function in JIA.]]> Wed 04 Sep 2019 10:24:10 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38127 Wed 04 Aug 2021 15:07:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52002 Tue 26 Sep 2023 11:30:29 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54869 Tue 19 Mar 2024 15:57:10 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31163 Tue 13 Nov 2018 09:56:34 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55635 Tue 11 Jun 2024 18:45:08 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34981 Tue 03 Sep 2019 18:19:17 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34782 Tue 03 Sep 2019 18:17:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34972 1 paediatric rheumatology case in the past month. Furthermore, 67.2% of participants felt their undergraduate education in paediatric rheumatology was inadequate. “Journals” or “texts books” were used by 49.3% of participants as their primary source of continuing professional development (CPD) and 39.3% of participants indicated that they did not undertake any CPD related to paediatric rheumatology. Small group and online education were perceived to be potentially of “great benefit” for CPD. Conclusion: This paper highlights allied health professionals’ and nurses’ perceived inadequacy of their undergraduate education in paediatric RD and their low confidence in recognising and treating RD. Undergraduate and postgraduate education opportunities focusing on interprofessional collaboration should be developed to address this workforce deficiency.]]> Tue 03 Sep 2019 17:57:41 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40065 Thu 28 Jul 2022 14:27:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45383 Thu 27 Oct 2022 13:03:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32059 n=83) of the surveyed cohort, and 41.2% (n=61) saw four or more different clinicians before diagnosis. Between symptom onset and final diagnosis, 42.6% (n=63) of participants reported a delay of 5 months or more, and 16.9% (n=25) waited longer than 12 months. Eventually, 91% (n=134) were referred to a paediatric rheumatologist and 63.5% (n=94) were seen within 4 weeks from initial referral. More than half the respondents felt that general practitioners (GPS) and general paediatricians were not aware of RD. Overall, respondents felt that improved knowledge of PR diseases among GPS, improved access to PR clinics, improved educational materials for patients and families, access to speciality rheumatology nurses and coordinated rheumatology teams would have significantly improved the experience of their child's disease. Conclusions: Children with RD in NSW still experience significant delays from symptom onset to final diagnosis through consultations with multiple healthcare professionals. Multidisciplinary team care was not the norm for this patient group, despite established national and international management standards. What is known about the topic? Early diagnosis and management by a multidisciplinary team is the gold standard in PR management. Delays in diagnosis may significantly impair the outcomes of children diagnosed with RD, with reduced quality of life, increased pain level and worse long-term prognosis. What does this paper add? Children diagnosed with RD in NSW endure significant delays from symptom onset until a final diagnosis is made, with multiple consultations with different healthcare professionals. When the referral to PR services in NSW is made, RD children are mostly seen within 4 weeks, faster than other international standards. GPS and paediatric rheumatologists in NSW helped improve the children's and their family's experience of the diagnosis and treatment of a rheumatic condition and better informed them using appropriate educational materials. What are the implications for practitioners' This paper provides new evidence to practitioners to increase their knowledge of the current experiences and expectation of the paediatric rheumatology care in NSW.]]> Thu 26 Apr 2018 14:45:52 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51747 Thu 21 Mar 2024 13:55:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36076 Thu 09 Dec 2021 11:02:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46839 Thu 01 Dec 2022 15:29:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31245 Sat 24 Mar 2018 08:44:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21154 Sat 24 Mar 2018 08:00:18 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21156 n= 16) were female and 46.7% (n= 14) were male. Mean age was 13.3 years (SD. = 4.5), with an age-range of 5-18.6 years old. Results indicated that for all variables tested the repeatability data were 'good' ICC for 73.8% (n= 121) and 'moderate' ICC for 26.2% (n= 43). For all variables tested, the reproducibility data showed that 'good' ICC for 70.7% (n= 58) and 'moderate' ICC for 29.3% (n= 24). In conclusion, the HR Walkway system is able to provide repeatable and reproducible data.]]> Sat 24 Mar 2018 08:00:18 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53515 Mon 15 Jan 2024 08:46:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52345 The purpose of this study was to evaluate the effect of custom-made orthotics on pain, health-related quality of life (HRQoL), function and fatigue in children and adolescents with generalised joint hypermobility (GJH) and lower limb pain. Fifty-three children aged 5–18 years were fitted with custom-made polypropylene orthotics. Visual analogue scale (VAS) assessed lower limb pain severity, Paediatric Quality of Life Inventory assessed HRQoL and fatigue and six-minute walk test (6 MWT) measured functional endurance at baseline, at 1 month and 3 months post-intervention. A mixed model including a random intercept for participant and a fixed effect for time was used to assess differences in outcomes over time. Fifty-two children completed the study (mean age 10.6-years). Children reported significantly reduced pain (mean VAS reduction −27/100, 95%CI: −33, −21), improved HRQoL (mean total improvement 11/100, 95%CI: 7, −15), functional capacity (mean 6MWT improvement 27 m, 95%CI: 18, −36) and fatigue (mean total improvement 13/100, 95%CI: 9, −17) after 1 month of wearing the custom-made orthotics. From 1 month to 3 months there was further statistically but not clinically significant reduction in pain while benefit on other outcomes was maintained. In this study, children with GJH reported reduced lower limb pain, improved HRQoL, functional endurance and fatigue after a month post-fitting of custom-made orthotics which was maintained over a 3 month period. Orthotics were well-tolerated with no serious adverse events reported.]]> Mon 09 Oct 2023 14:57:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23874 Fri 28 Oct 2016 11:55:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33971 Fri 25 Jan 2019 14:41:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51892 Fri 22 Sep 2023 09:23:28 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37584 Fri 19 Feb 2021 15:58:52 AEDT ]]>